Verantos Inc.
Menlo Park, CA
- UEI
- C164SJKTL3J5
- CAGE
- 83TN6
- Primary NAICS
- 541511 Custom Computer Programming Services
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 325 Sharon Park Dr #730, Menlo Park, CA 94025, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $2,982,375 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| BAA FY24C1JP9- "valid evidence and reliable real-world data increasing fidelity and yielding clarity in regulatory… | Food and Drug Administration | $2,982,375 |
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Insilica Inc. | Bethesda, MD | 541511 Custom Computer Programming Services |
| Ursa Analytics, Inc. | Denver, CO | 541511 Custom Computer Programming Services |
| Digital Medicine Society Inc. | Boston, MA | 813212 Voluntary Health Organizations |
| C-Path | Tucson, AZ | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Latham Biopharm Group | Elkridge, MD | 541690 Other Scientific and Technical Consulting Services |
About the company
Verantos Inc. is a for-profit corporate entity registered in SAM.gov that specializes in providing advanced data and evidence generation services for regulatory and scientific research, particularly in the healthcare and pharmaceutical domains. The company focuses on developing complex data analysis techniques, with an emphasis on transforming unstructured and structured clinical data to support regulatory decision-making processes. Based on its federal award history, Verantos appears to be a technology-driven research organization that leverages artificial intelligence and advanced analytical methodologies to generate high-quality real-world evidence for government agencies.
Through its federal contract work, Verantos Inc. has secured a significant contract with the Food and Drug Administration (FDA) valued at $2,982,375.00, specifically focused on generating valid evidence and reliable real-world data to enhance regulatory decision-making. The contract, identified as "VALID EVIDENCE AND RELIABLE REAL-WORLD DATA INCREASING FIDELITY AND YIELDING CLARITY IN REGULATORY DECISION-MAKING (VERIFY)", is a firm fixed-price definitive contract without any set-aside designations. The contract's primary objective is to provide innovative products and services that support the FDA's regulatory processes, demonstrating Verantos' capability to develop sophisticated data analysis solutions for complex governmental research needs.
Regarding federal grant awards, Verantos Inc. has received multiple cooperative agreements from civilian agencies, particularly focusing on advanced clinical data research. The National Science Foundation awarded a Phase II SBIR grant for determining complex outcome measures using narrative clinical data to enable observational trials, while the Center for Drug Evaluation and Research funded a project titled "TRANSFORMING REAL-WORLD EVIDENCE WITH UNSTRUCTURED AND STRUCTURED DATA TO ADVANCE TAILORED THERAPY (TRUST)". These grant awards underscore Verantos' expertise in developing advanced methodologies for analyzing clinical data, with a specific emphasis on creating innovative approaches to extract meaningful insights from complex, unstructured medical information to support personalized medical research and regulatory assessments.
Quick answers
Is Verantos Inc. registered in SAM.gov?
Yes. Verantos Inc.'s SAM.gov registration is active through September 8, 2027.
What is Verantos Inc.'s CAGE code?
Verantos Inc.'s CAGE code is 83TN6, and its Unique Entity ID (UEI) is C164SJKTL3J5.
How much has Verantos Inc. received in federal contracts?
Federal contracts obligated $2,982,375 to Verantos Inc. in fiscal years 2023 through 2027.
What is Verantos Inc.'s most recent federal award?
Verantos Inc.'s most recent federal contract award is BAA FY24C1JP9- "valid evidence and reliable real-world data increasing fidelity and yielding clarity in regulatory… (75F40124C00119), from Food and Drug Administration, on September 20, 2024.
On GovTribe
See Verantos Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors